COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,959 Articles (22,604 medRxiv, 8,355 bioRxiv)

Most recent first Previous |  Page 318: Articles 3171-3180  | Next

Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection
Lane, G., Zhou, G., Hultquist, J. F., Simons, L. M., Lorenzo-Redondo, R., Ozer, E. A., McCarthy, D. M., Ison, M. G., Achenbach, C. J., Wang, X., Wai, C. M., Wyatt, E., Aalsburg, A., Yang, Q., Noto, T., Alisoltani, A., Ysselstein, D., Awatramani, R., Murphy, R., Theron, G., Zelano, C.
10.1101/2023.09.06.23295138 — Posted: 2023-09-08
Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY
Schaffer, A. L., Hulme, W. J., Horne, E. M. F., Parker, E. P. K., Walker, V., Stables, C., Mehrkar, A., Bacon, S. C. J., Bates, C., Goldacre, B., Walker, A. J., The OpenSAFELY Collaborative, , Hernan, M. A., Sterne, J. A. C.
10.1101/2023.09.07.23295194 — Posted: 2023-09-08
Effectiveness of BNT162b2 COVID-19 Vaccination in Children Aged 5-17 Years in the United States
Ogilvie, R. P., Layton, J. B., Lloyd, P. C., Jiao, Y., Djibo, D. A., Wong, H. L., Gruber, J. F., Parambi, R., Deng, J., Miller, M., Song, J., Weatherby, L. B., Peetluk, L., Lo, A.-C., Matuska, K., Wernecke, M., Bui, C. L., Clarke, T. C., Cho, S., Bell, E. J., Yang, G., Amend, K. L., Forshee, R. A., Anderson, S. A., McMahill-Walraven, C. N., Chillarige, Y., Anthony, M. S., Seeger, J. D., Shoaibi, A.
10.1101/2023.09.06.23294426 — Posted: 2023-09-08
Comparison of Different PCR Methods for the Detection of SARS-CoV-2 RNA in Wastewater Based on the Reported Incidence of COVID-19 in Finland
Länsivaara, A. I., Lehto, K.-M., Hyder, R., Janhonen, E., Lipponen, A., Heikinheimo, A., Pitkänen, T., Oikarinen, S., WastPan study group
10.1101/2023.09.07.23295183 — Posted: 2023-09-08
Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
Katzmarzyk, M., Clesle, D. C., van den Heuvel, J., Hoffmann, M., Garritsen, H., Poehlmann, S., Jacobsen, H., Cicin-Sain, L.
10.1101/2023.09.08.23295177 — Posted: 2023-09-08
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
Azeez, R., Lotoski, L., Winsor, G. L., Arnold, C. R., Galipeau, Y., Pelchat, M., Goguen, S., Simons, E., Moraes, T. J., Mandhane, P. J., Turvey, S. E., Bolotin, S., Patrick, D. M., Bullard, J., Lix, L. M., Doucas, N., Rodriguez, N., Brinkman, F. S. L., Subbarao, P., Langlois, M.-A., Azad, M.
10.1101/2023.09.06.23294696 — Posted: 2023-09-08
Uncovering the implications of IFN-I in severe COVID-19 neutrophil inflammasome
Cabrera, L. E., Jokiranta, S. T., Mäki, S., Miettinen, S., Kant, R., Kareinen, L., Sironen, T., Pietilä, J.-P., Kantele, A., Kekäläinen, E., Lindgren, H., Mattila, P., Kipar, A., Vapalahti, O., Strandin, T.
10.1101/2023.09.07.23295190 — Posted: 2023-09-08
Disease trajectories in hospitalized COVID-19 patients are predicted by clinical and peripheral blood signatures representing distinct lung pathologies.
Silva Filho, J. L., Herder, V., Gibbins, M. P., dos Reis, M. F. F., Melo, G. C., Haley, M., Judice, C. C., Val, F. F. A., Borba, M., Tavella, T. A., Sampaio, V. S., Attipa, C., McMonagle, F., de Lacerda, M. V. G., Costa, F. T. M., Couper, K. N., Monteiro, W. M., Ferreira, L. C. d. L., Moxon, C. A., Palmarini, M., Marti, M.
10.1101/2023.09.08.23295024 — Posted: 2023-09-08
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khan, K., Lustig, G., Reedoy, K., Jule, Z., Romer, C., Karim, F., Ganga, Y., Bernstein, M., Baig, Z., Mahlangu, B., Mnguni, A., Nzimande, A., Stock, N., Kekana, D., Ntozini, B., van Deventer, C., Marshall, T., Manickchund, N., Gosnell, B., Lessells, R., Abdool Karim, Q., Abdool Karim, S. S., Moosa, Y., de Oliveira, T., von Gottberg, A., Wolter, N., Neher, R. A., Sigal, A.
10.1101/2023.09.08.23295250 — Posted: 2023-09-08
Early combination with remdesivir, nirmatrelvir/ritonavir and sotrovimab for the treatment of COVID-19 in immunocompromised hosts
Gentile, I., Foggia, M., Silvitelli, M., Sardanelli, A., Cattaneo, L., Viceconte, G., Federico II COVID team
10.1101/2023.09.07.23295202 — Posted: 2023-09-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).